Search research articles
Contact Us
Filters
Showing results (91-100 of 117) with videos related to
Page
of 12
Sort By:
American Journal of Clinical Oncology
|
May 8, 2013
Lenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II study
Howard Safran, Kevin P Charpentier, Andreas Kaubisch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2017
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer
Axel Grothey, Jonathan R Strosberg, Lindsay A Renfro, et al.
Journal of Hematology & Oncology
|
January 1, 2020
Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway
Kosuke Ogawa, Qiushi Lin, Le Li, et al.
JAMA Oncology
|
July 9, 2017
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial
Mohan Suntharalingam, Kathryn Winter, David Ilson, et al.
American Journal of Clinical Oncology
|
December 15, 2015
PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study: BrUOG 244
Heinrich Elinzano, Michael Glantz, Maciej Mrugala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2017
Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study
Andrea B Apolo, Jeffrey R Infante, Ani Balmanoukian, et al.
Cancer Investigation
|
December 8, 2004
Trastuzumab, paclitaxel, cisplatin, and radiation for adenocarcinoma of the esophagus: a phase I study
Howard Safran, Thomas DiPetrillo, Ahmed Nadeem, et al.
Cancer Letters
|
March 8, 2020
Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis
Kosuke Ogawa, Qiushi Lin, Le Li, et al.
Cancer Letters
|
November 21, 2025
Corrigendum to "Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis" [Cancer Lett. 481 (2020) 63-75]
Kosuke Ogawa, Qiushi Lin, Le Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2016
Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target
Evgeny Yakirevich, Murray B Resnick, Shamlal Mangray, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 117) with videos related to
Sort By:
Page
of 12
American Journal of Clinical Oncology
|
May 8, 2013
Lenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II study
Howard Safran, Kevin P Charpentier, Andreas Kaubisch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2017
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer
Axel Grothey, Jonathan R Strosberg, Lindsay A Renfro, et al.
Journal of Hematology & Oncology
|
January 1, 2020
Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway
Kosuke Ogawa, Qiushi Lin, Le Li, et al.
JAMA Oncology
|
July 9, 2017
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial
Mohan Suntharalingam, Kathryn Winter, David Ilson, et al.
American Journal of Clinical Oncology
|
December 15, 2015
PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study: BrUOG 244
Heinrich Elinzano, Michael Glantz, Maciej Mrugala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2017
Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study
Andrea B Apolo, Jeffrey R Infante, Ani Balmanoukian, et al.
Cancer Investigation
|
December 8, 2004
Trastuzumab, paclitaxel, cisplatin, and radiation for adenocarcinoma of the esophagus: a phase I study
Howard Safran, Thomas DiPetrillo, Ahmed Nadeem, et al.
Cancer Letters
|
March 8, 2020
Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis
Kosuke Ogawa, Qiushi Lin, Le Li, et al.
Cancer Letters
|
November 21, 2025
Corrigendum to "Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis" [Cancer Lett. 481 (2020) 63-75]
Kosuke Ogawa, Qiushi Lin, Le Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2016
Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target
Evgeny Yakirevich, Murray B Resnick, Shamlal Mangray, et al.
Page
of 12